ClinicalTrials.gg
Status unknownNCT06565754BFRUpdated Aug 22, 2024

Effect of Adding Blood Flow Restriction to Strengthening Exercise in Patients With Patellofemoral Pain Syndrome

An interventional study of BFR and strengthening exercise in BFR, PFPS and Strengthening Exercises, sponsored by Cairo University. Status unknown at 1 site in Egypt. Open to participants aged 18 Years to 35 Years. Per ClinicalTrials.gov, last updated 2024-08-22.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Aug 2024), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
All
01

Study summary

To study the effect of adding BFRT to strengthening exercises and compare it with strengthening exercises alone in improving, muscular strength, pain, function, joint position sense, and dynamic balance test (star excursion test). in patients with PFPS.

Read the detailed description

Background: Patellofemoral Pain Syndrome (PFPS) is a common condition characterized by anterior knee pain, particularly affecting individuals aged 15-30. It often involves lower limb muscle weakness, particularly in the quadriceps, which can exacerbate symptoms and affect functional performance. Blood Flow Restriction Training (BFRT) has shown promise in enhancing muscle strength and functional outcomes with reduced intensity compared to traditional high-intensity training.

Purpose: This study aims to compare the efficacy of combining BFRT with traditional strengthening exercises versus using strengthening exercises alone in improving muscular strength, pain, function, joint position sense, and dynamic balance in patients with PFPS.

Methods: A triple-blinded, randomized controlled trial was conducted at the Almenshawy General Hospital, Tanta, Egypt. Fifty patients with unilateral non-traumatic PFPS, aged 18-35, were randomly assigned to either a strengthening exercises group (SE Group) or a BFRT plus strengthening exercises group (BFRT Group). Both groups underwent a 6-week intervention with three sessions per week. Outcomes assessed included quadriceps and hip abductors strength, pain severity (Visual Analog Scale), functional status (Kujala Patellofemoral Score), joint position sense (measured by digital inclinometer), and dynamic balance (Star Excursion Balance Test).

02

Conditions studied

  • BFR
  • PFPS
  • Strengthening Exercises
  • Quadriceps Strength
  • Dynamic Balance
  • Joint Position Sense

Keywords

  • PFPS
  • Patellofemoral Pain Syndrome
  • Blood Flow Restriction Training
  • Strengthening Exercises
  • Dynamic Balance
03

In context

Patellofemoral Pain Syndrome

299 studies on the registry are indexed under Patellofemoral Pain Syndrome; 74 are open to participants now.

This study's planned enrollment of 50 is close to the median of 46 across 246 interventional studies indexed under Patellofemoral Pain Syndrome.

Browse Patellofemoral Pain Syndrome studies →

Lead sponsor

Cairo University is the lead sponsor of 4,909 studies on the registry; 1,445 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient referred from Orthopedic surgeon with diagnosis of patellofemoral pain syndrome PFPS.
  • Both genders.
  • BMI ranges from 18.5 to 29.9.
  • Age ranges between 18 and 40 years experienced non-traumatic PFPS onset of anterior knee pain for greater than 2 weeks.
  • Pain with any two activities, including running, jumping, squatting, kneeling, stair ascent/descent or prolonged sitting.

Exclusion criteria

Exclusion Criteria:

  • Coexisting pathology around the knee, including patellar subluxation or dislocation.
  • Other sources of anterior knee pain (bursa, fat pad).
  • Previous knee surgery.
  • Suspicion of patellar tendinopathy, with strong consideration of pain localised to the patellar tendon.
  • Any cardiovascular disease.
  • Uncontrolled hypertension.
  • Any lower limb trauma.
  • Hip and ankle pathology.
  • BMI more than 30%.
  • Pregnancy.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • Active comparator
    strengthening exercises group (SE Group)

    all patients will receive : 1. Isometric quadriceps exercise - 3 sets of 20 repetitions (5 s). 2. Straight leg raise (SLR) with 3 sets - 20 repetitions. 3. Short arc knee extension exercise - 3 sets of 20 repetitions. 4. Hip abduction from side lying - 3 sets of 20 repetitions.

    Other: strengthening exercise

  • Experimental
    BFRT plus strengthening exercises group (BFRT Group)

    all patients will receive the below exercises using BFR cuff : 1. Isometric quadriceps exercise - 3 sets of 20 repetitions (5 s). 2. Straight leg raise (SLR) with 3 sets - 20 repetitions. 3. Short arc knee extension exercise - 3 sets of 20 repetitions. 4. Hip abduction from side lying - 3 sets of 20 repetitions.

    Other: BFR · Other: strengthening exercise

Interventions

  • OtherBFR

    Blood flow restriction training is an accessory to a variety of different exercise modes (e.g., resistance exercise, walking, cycling) has recently become a popular research topic. It involves the application of pressurized cuffs to the proximal portion of each lower extremity or upper extremity. It enhance blood pooling in the capillary beds of the limb muscles distal to the tourniquet or cuff. The 3rd Generation SmartCuffs® pump (SmartCuffs® 3.0 PRO) is Personalized Pressure feature which allows for a fast, hassle-free personalized pressure calculation. With the built-in pressure sensor and on-board computer, it is calculate arterial occlusion pressure and set the optimal pressure for patient's body. There is no need for an external doppler probe or hand pump. This unit will do everything for patient. Smart Cuffs 3rd generation is FDA Approved Listed Class 1 device. The automatized tourniquet (Smart Tools) contains a ring-shaped single- chamber

  • Otherstrengthening exercise

    Quadriceps strengthening exercises are part of the treatment of PFPS, but the heavy resistance exercises may aggravate knee pain. Blood flow restriction training (BFRT) provides a low-load quadriceps strengthening method to treat PFPS (Giles et al., 2017).

06

What researchers measure

Primary outcomes

  1. quadriceps and hip abductors strength

    Hand-Held Dynamometer (HHD). The Lafayette® HHD is a valid and reliable instrument of low cost and easy handling compared to the isokinetic dynamometer for assessment of muscle strength

    Time frame: 6 weeks

Secondary outcomes

  1. pain severity using Visual Analog Scale (VAS)

    The Visual Analog Scale is determined by measuring in millimeters from the left end of the line to the patient's mark. Participants will ask to determine the point at which pain represents the severity of pain maximum is 10 while lowest level of pain is zero

    Time frame: 6 weeks

  2. functional status (Kujala Patellofemoral Score)

    The 13 items on the scale are used to assess subjective symptoms and functional restrictions. A score can have a minimum of 0 points or a maximum of 100 points.

    Time frame: 6 weeks

  3. joint position sense (measured by digital inclinometer)

    Digital Inclinometer for joint position sense assessment. Device (Digital Protractor, 82201b-00, INSPEC, China) The inclinometer is a valid and reliable method to assess the knee proprioception through JPS in open kinetic chain

    Time frame: 6 weeks

  4. dynamic balance (Star Excursion Balance Test

    Four strips of adhesive tape will need to be cut to a length of 6-8 feet each. Two pieces will be used to form a '+', with the other two being placed over top to form an 'x' so that a star shape is formed. It is important that all lines are separated from each other by a 45° angle. The goal of the Star Excursion Balance Test (SEBT) is to maintain single leg stance on one leg while reaching as far as possible with the contralateral leg.

    Time frame: 6 weeks

07

Study locations

1 site
  • Cairo University
    Giza, 12613, Egypt
    • enas F youssef, Professor · Contact · enas.fawzy@pt.cu.edu.eg · +201127867507
    • abdelgalil A shaaban, PhD · Contact · abdelgalildr@gmail.com · +201146937036
    • ahmed S helal, PhD · Principal investigator
    • ahmed M khalil, PhD · Principal investigator
    • abdelgalil A shaaban, PhD · Principal investigator
08

References and documents

Publications

  • Stefanov F, Morris L, Elhelali A, Kavanagh EP, Lundon V, Hynes N, Sultan S. Insights from complex aortic surgery with a Streamliner device for aortic arch repair (STAR). J Thorac Cardiovasc Surg. 2016 Nov;152(5):1309-1318.e5. doi: 10.1016/j.jtcvs.2016.06.043. Epub 2016 Jun 29. PubMed 27485677 ↗
  • Sigaud O, Stulp F. Policy search in continuous action domains: An overview. Neural Netw. 2019 May;113:28-40. doi: 10.1016/j.neunet.2019.01.011. Epub 2019 Feb 5. PubMed 30780043 ↗
  • Golbs A, Nimmervoll B, Sun JJ, Sava IE, Luhmann HJ. Control of programmed cell death by distinct electrical activity patterns. Cereb Cortex. 2011 May;21(5):1192-202. doi: 10.1093/cercor/bhq200. Epub 2010 Oct 21. PubMed 20966045 ↗
  • Panneton WM, Gan Q, Juric R. The rat: a laboratory model for studies of the diving response. J Appl Physiol (1985). 2010 Apr;108(4):811-20. doi: 10.1152/japplphysiol.00600.2009. Epub 2010 Jan 21. PubMed 20093670 ↗
  • Wang H, Li Y, Zhang C, Han Y, Zhang X, Zhu T, Li T. Immunological and virological responses to cART in HIV/HBV co-infected patients from a multicenter cohort. AIDS. 2012 Sep 10;26(14):1755-63. doi: 10.1097/QAD.0b013e328355ced2. PubMed 22614885 ↗
  • Zhang A, Mo X, Zhou N, Wang Y, Wei G, Chen J, Chen K, Ouyang P. A novel bacterial beta-N-acetyl glucosaminidase from Chitinolyticbacter meiyuanensis possessing transglycosylation and reverse hydrolysis activities. Biotechnol Biofuels. 2020 Jun 29;13:115. doi: 10.1186/s13068-020-01754-4. eCollection 2020. PubMed 32612678 ↗
  • Ziegler MG, Milic M, Lu X, Gharaibeh M, Elayan H. Effect of obstructive sleep apnea on the response to hypertension therapy. Clin Exp Hypertens. 2017;39(5):409-415. doi: 10.1080/10641963.2016.1259327. Epub 2017 May 30. PubMed 28557555 ↗
  • Herzog N, Hartkamp JD, Verheugd P, Treude F, Forst AH, Feijs KL, Lippok BE, Kremmer E, Kleine H, Luscher B. Caspase-dependent cleavage of the mono-ADP-ribosyltransferase ARTD10 interferes with its pro-apoptotic function. FEBS J. 2013 Mar;280(5):1330-43. doi: 10.1111/febs.12124. Epub 2013 Feb 13. PubMed 23305266 ↗
  • Barrett CL, Mann GE, Taylor PN, Strike P. A randomized trial to investigate the effects of functional electrical stimulation and therapeutic exercise on walking performance for people with multiple sclerosis. Mult Scler. 2009 Apr;15(4):493-504. doi: 10.1177/1352458508101320. Epub 2009 Mar 12. PubMed 19282417 ↗
  • Parnia S, Yang J, Nguyen R, Ahn A, Zhu J, Inigo-Santiago L, Nasir A, Golder K, Ravishankar S, Bartlett P, Xu J, Pogson D, Cooke S, Walker C, Spearpoint K, Kitson D, Melody T, Chilwan M, Schoenfeld E, Richman P, Mills B, Wichtendahl N, Nolan J, Singer A, Brett S, Perkins GD, Deakin CD. Cerebral Oximetry During Cardiac Arrest: A Multicenter Study of Neurologic Outcomes and Survival. Crit Care Med. 2016 Sep;44(9):1663-74. doi: 10.1097/CCM.0000000000001723. PubMed 27071068 ↗
  • Galvez-Martinez S, Mateo-Marti E. Ultraviolet Irradiation on a Pyrite Surface Improves Triglycine Adsorption. Life (Basel). 2018 Oct 25;8(4):50. doi: 10.3390/life8040050. PubMed 30366364 ↗
  • Saade Riachy C, Nemr E. Medical professionalism in Lebanon: between doctors' perception and patients' satisfaction. Int J Med Educ. 2020 Aug 21;11:171-172. doi: 10.5116/ijme.5f28.77a3. No abstract available. PubMed 32827248 ↗
  • Maher SK, Wojnarowicz P, Ichu TA, Veldhoen N, Lu L, Lesperance M, Propper CR, Helbing CC. Rethinking the biological relationships of the thyroid hormones, l-thyroxine and 3,5,3'-triiodothyronine. Comp Biochem Physiol Part D Genomics Proteomics. 2016 Jun;18:44-53. doi: 10.1016/j.cbd.2016.04.002. Epub 2016 Apr 7. PubMed 27085304 ↗
  • Ozbay B, Uzun K, Arslan H, Zehir I. Functional and radiological impairment in women highly exposed to indoor biomass fuels. Respirology. 2001 Sep;6(3):255-8. doi: 10.1046/j.1440-1843.2001.00339.x. PubMed 11555385 ↗
  • Martelletti P, Schwedt TJ, Lanteri-Minet M, Quintana R, Carboni V, Diener HC, Ruiz de la Torre E, Craven A, Rasmussen AV, Evans S, Laflamme AK, Fink R, Walsh D, Dumas P, Vo P. My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed. J Headache Pain. 2018 Nov 27;19(1):115. doi: 10.1186/s10194-018-0946-z. PubMed 30482181 ↗
  • Esparza Martin N. [Hypotonic hiponatremia. Differential diagnosis]. Med Clin (Barc). 2016 Dec 2;147(11):507-510. doi: 10.1016/j.medcli.2016.09.013. Epub 2016 Oct 27. No abstract available. Spanish. PubMed 28126145 ↗
  • Jagadeesh AT, Puttur A, Mondal S, Ibrahim S, Udupi A, Prasanna LC, Kamath A. Devising focused strategies to improve organ donor registrations: A cross-sectional study among professional drivers in coastal South India. PLoS One. 2018 Dec 21;13(12):e0209686. doi: 10.1371/journal.pone.0209686. eCollection 2018. PubMed 30576381 ↗
  • Huijbers MG, Querol LA, Niks EH, Plomp JJ, van der Maarel SM, Graus F, Dalmau J, Illa I, Verschuuren JJ. The expanding field of IgG4-mediated neurological autoimmune disorders. Eur J Neurol. 2015 Aug;22(8):1151-61. doi: 10.1111/ene.12758. Epub 2015 May 29. PubMed 26032110 ↗
  • Selak V, Webster R, Stepien S, Bullen C, Patel A, Thom S, Arroll B, Bots ML, Brown A, Crengle S, Dorairaj P, Elley CR, Grobbee DE, Harwood M, Hillis GS, Laba TL, Neal B, Peiris D, Rafter N, Reid C, Stanton A, Tonkin A, Usherwood T, Wadham A, Rodgers A. Reaching cardiovascular prevention guideline targets with a polypill-based approach: a meta-analysis of randomised clinical trials. Heart. 2019 Jan;105(1):42-48. doi: 10.1136/heartjnl-2018-313108. Epub 2018 Jun 28. PubMed 29954855 ↗
  • Muoio R, Caretti C, Rossi L, Santianni D, Lubello C. Letter to the Editor: Water safety plans and risk assessment: A novel procedure applied to treated water turbidity and gastrointestinal diseases. Int J Hyg Environ Health. 2020 Aug;229:113455. doi: 10.1016/j.ijheh.2020.113455. Epub 2020 Jan 25. No abstract available. PubMed 31992522 ↗
  • Nakao S, Platek A, Hirano S, Takeichi M. Contact-dependent promotion of cell migration by the OL-protocadherin-Nap1 interaction. J Cell Biol. 2008 Jul 28;182(2):395-410. doi: 10.1083/jcb.200802069. Epub 2008 Jul 21. PubMed 18644894 ↗
  • Kasten P, Pape G, Raiss P, Bruckner T, Rickert M, Zeifang F, Loew M. Mid-term survivorship analysis of a shoulder replacement with a keeled glenoid and a modern cementing technique. J Bone Joint Surg Br. 2010 Mar;92(3):387-92. doi: 10.1302/0301-620X.92B3.23073. PubMed 20190310 ↗
  • Froon-Torenstra D, Beket E, Khader AM, Hababeh M, Nasir A, Seita A, Benninga MA, van den Berg MM. Prevalence of functional constipation among Palestinian preschool children and the relation to stressful life events. PLoS One. 2018 Dec 6;13(12):e0208571. doi: 10.1371/journal.pone.0208571. eCollection 2018. PubMed 30521620 ↗
  • Abe T, Kearns CF, Sato Y. Muscle size and strength are increased following walk training with restricted venous blood flow from the leg muscle, Kaatsu-walk training. J Appl Physiol (1985). 2006 May;100(5):1460-6. doi: 10.1152/japplphysiol.01267.2005. Epub 2005 Dec 8. PubMed 16339340 ↗
  • Abe T, Fujita S, Nakajima T, Sakamaki M, Ozaki H, Ogasawara R, Sugaya M, Kudo M, Kurano M, Yasuda T, Sato Y, Ohshima H, Mukai C, Ishii N. Effects of Low-Intensity Cycle Training with Restricted Leg Blood Flow on Thigh Muscle Volume and VO2MAX in Young Men. J Sports Sci Med. 2010 Sep 1;9(3):452-8. eCollection 2010. PubMed 24149640 ↗
  • Abbas MJ, Dancy ME, Marigi EM, Khalil LS, Jildeh TR, Buckley PJ, Gillett J, Burgos W, Okoroha KR. An Automated Technique for the Measurement of Limb Occlusion Pressure During Blood Flow Restriction Therapy Is Equivalent to Previous Gold Standard. Arthrosc Sports Med Rehabil. 2022 May 28;4(3):e1127-e1132. doi: 10.1016/j.asmr.2022.04.002. eCollection 2022 Jun. PubMed 35747637 ↗
  • Penailillo L, Blazevich AJ, Nosaka K. Factors contributing to lower metabolic demand of eccentric compared with concentric cycling. J Appl Physiol (1985). 2017 Oct 1;123(4):884-893. doi: 10.1152/japplphysiol.00536.2016. Epub 2017 Jun 29. PubMed 28663378 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2024; primary completion for Apr 2025, 7 months later.

Of 154 non-industry interventional studies with no phase under Patellofemoral Pain Syndrome, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 20. This study's planned 7 months is below that.

Counting every sponsor, half of 158 studies reached it within 11 months; a quarter within 4 and three quarters within 21.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 26, 2024
First posted
Aug 22, 2024
StartEst.
Sep 1, 2024
Primary completionEst.
Apr 1, 2025
CompletionEst.
Apr 1, 2026
Last update
Aug 22, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 22, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06565754
Lead sponsor
Cairo University
Responsible party
Ahmed Mohamed Mahmoud Abdelaziz Khalil (doctor, Cairo University) — Principal investigator
First posted
Aug 22, 2024
Start date
Sep 1, 2024 (estimated)
Primary completion
Apr 1, 2025 (estimated)
Completion
Apr 1, 2026 (estimated)
Last update
Aug 22, 2024

Study contacts

ABDELRAHMAN M HEWID, MSc
Contact
dr.abdelrahman.hewidy.94@gmail.com
9294358403 ext. 9294358403
ahmed M khalil, PhD
Contact
ahmed.khalil@pua.edu.eg
9294358403
enas F youssef, Professor
study chair · Cairo University
abdelgalil A shaaban, PhD
study director · Cairo University
ahmed S helal, PhD
study director · Tanta University
ahmed M khalil, PhD
study director · Pharos University in Alexandria

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion